Pathological diagnosis of melanocytic tumours: clues and pitfalls # Richard A. Scolyer 1,2,3* and Stanley W. McCarthy 1,2,3
|
|
- Juniper Cox
- 5 years ago
- Views:
Transcription
1 Pathological diagnosis of melanocytic tumours: clues and pitfalls # Richard A. Scolyer 1,2,3* and Stanley W. McCarthy 1,2,3 1 Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. 2 Melanoma Institute Australia, Sydney, Australia. 3 Discipline of Pathology, Sydney Medical School, The University of Sydney, NSW, Australia. *Supported by a Cancer Institute New South Wales Clinical Research Fellowship In Australia and many other countries, melanoma is a major public health problem particularly in those individuals of Celtic ancestry. Other races are not immune, especially when acral and mucosal sites are taken into account. Accurate diagnosis requires the balancing of clinical data (including patient age and sex, family history, the anatomic site of the lesion, the history of the lesion and other factors such as a history of trauma, sunburn or pregnancy), histological features (including architecture, cytology and the host response), awareness of pitfalls and judgment. Several types of naevi are prone to be misdiagnosed as melanoma such as regenerating naevi, combined naevi, acral naevi, deep penetrating naevi and Spitz naevi. Melanomas often underdiagnosed include naevoid melanomas, desmoplastic melanomas, Spitzoid melanomas and regressed melanomas. The type of biopsy and suboptimal processing may also significantly influence the diagnosis. PATHOLOGICAL DIAGNOSIS Accurate pathological diagnosis of melanocytic tumours requires a suitable biopsy, assessment of many histological criteria, an awareness of potential pitfalls, relevant experience and, in difficult cases, judicious consultation 1-5. Correlation of a range of basic morphological and clinical features is necessary because many of the individual features are shared by both naevi and melanomas. In the future, molecular and genetic studies may be useful adjuncts for an accurate diagnosis, particularly for difficult lesion for which it is not possible to be certain from its histological features whether the lesion is benign or malignant Morphological features of importance (Table 1): Architectural: Good symmetry is often associated with benign behaviour. Poor symmetry and irregular margins are more often found in dysplastic, traumatised and malignant melanocytic tumours. Ulceration, vascular invasion, neurotropism and satellites are also more frequent in melanomas but can also occasionally occur in naevi. Minor perineural invasion may be found in all types of benign naevi so is not very helpful when diagnosing melanocytic tumours. Pagetoid epidermal invasion is very common and not usually significant in acral lesions, regenerating naevi ( pseudomelanoma ) or irritated naevi (trauma, sunburn etc.) 5 9.
2 Cytological: Cytological features may be deceptive especially in naevoid melanomas with small cells and uniform cytology, deep penetrating naevi with nuclear pleomorphism and regenerating naevi with epithelioid cells. Nucleoli when irregular or frequent (average > 2 nucleus) usually indicate dysplasia or malignancy. Mitoses when abnormal, frequent (>2/mm²) or deep in the lesion are always of concern and should be regarded as being of at least uncertain malignant potential especially when occurring in post pubertal patients. Host response: This is usually cellular and/or stromal. Cellular: Regressing tumours, benign or malignant, are usually infiltrated, at least initially, by lymphocytes. Scattered foci of lymphocytes are a common feature in desmoplastic melanoma. Benign naevi and some aggressive epithelioid melanomas lack a cellular response. Stromal: Periretal lamellar collagen is common in dysplastic naevi and may be very thick in severe forms. Fibrosis is variable in desmoplastic melanoma. Pure forms (100% desmoplastic) appear to have a better prognosis and less frequent nodal metastases 10. Table 1: Morphological Features of Melanoma Architectural Asymmetry Irregular margins Ulceration Vascular invasion Microsatellites Pagetoid epidermal invasion Cytological Nucleoli (especially if irregular and multiple) Deep or frequent mitoses Poor maturation Host response Lymphocytic infiltrate Stromal fibrosis (especially in desmoplastic melanoma) Regression Clinical features of importance: Age: Melanomas are uncommon in children just as Spitz naevi are rare in middle and older age groups. Vulval melanoma is rare below the age of 40 years. Sex: Melanomas with Spitzoid features appear to be more common in young males but the reverse is probably true after Females have a better prognosis than male melanoma patients. Family history: Melanomas are common in some families and first degree relatives.
3 Site: Sun-exposed areas are more likely to develop naevi and melanomas in Caucasian patients. Desmoplastic melanomas most commonly involve the head and neck region and are frequently associated with lentigo maligna 12. They may be subtle clinically and histologically and hence may not be diagnosed until they are at an advanced clinical stage. 9 History of lesion: A lesion of long duration which has changed in size or color, become itchy, or bled easily should always be investigated. Any trauma, previous biopsy, sunburn or topical agent may induce regenerative features that simulate malignancy. Pregnancy: May induce frequent mitoses in otherwise banal naevi. THE BIOPSY An excisional biopsy is preferred wherever possible Lesser specimens (punch, shave, curettings) may be distorted and may not permit adequate assessment of the vital parameters needed by the clinician for definitive treatment e.g. Breslow thickness, mitotic rate 13. Smaller specimens may also not be representative of the lesion and usually lack the edges and bases of the lesions needed to assist diagnostic interpretation 3 4. In the subsequent excision specimen it may be impossible to allocate atypical features cellular pleomorphism, mitoses and epidermal invasion to either malignancy or regeneration. A recent study highlighted that histopathological misdiagnosis is more common for melanomas that have been assessed with punch and shave biopsy than with excision biopsy 34. Adverse outcomes due to misdiagnosis were more commonly associated with punch biopsy than with shave and excision biopsy (odds ratio 16.6, p<0.001). The use of punch and shave biopsy also leads to increased microstaging inaccuracy. It is often difficult to separate traumatic fibrosis from regression fibrosis. The latter is more often associated with epidermal atrophy whereas post-traumatic fibrosis in compound naevi often has some overlying variable epidermal thickening. NAEVI PRONE TO MISDIAGNOSIS (Table 2) Table 2: Naevi Prone to Misdiagnosis Regenerating nevus Blue naevi Irritated naevus - Dendritic Post-excisional junctional hyperplasia - Cellular Cellular/hyperplastic nodule - Deep penetrating in congenital naevus - Epithelioid Combined naevus Acral naevi Ancient naevus Balloon and Clear cell naevi Spitz naevus Neurotized naevus Dysplastic naevus Desmoplastic naevus Naevus in pregnancy Halo naevus Genital naevus
4 Regenerating Naevi. Naevi often regenerate after incomplete removal (punch, shave, curette, incision, other trauma). Some naevi, especially compound melanocytic naevi of small congenital type and dysplastic compound naevi, display features often associated with melanoma and are sometimes termed pseudomelanoma. These features include Pagetoid spread of melanocytes, cytological atypia, dermal mitoses and HMB45 positivity. 14 Post-excisional junctional melanocytic hyperplasia at the edge of an excision scar may show some atypia and a tendency to epidermal invasion suggestive of in situ malignancy. Irritated melanocytic naevi may show epidermal invasion but the offending melanocytes tend to have small nuclei. Causes of irritation may be physical e.g. rubbing or scratching, topical agents or strong sunburn. Dysplastic naevi have variable lentiginous hyperplasia, periretal lamellar collagen, architectural disorder and cytological atypia. The cytological atypia may be mild, moderate or severe. Severe atypia or moderate atypia associated with irritative or Spitzoid changes may readily be mistaken for malignancy. The vast majority of dysplastic naevi (the commonest naevi in Caucasians) with mild to moderate cytological atypia are stable or grow very slowly and rarely progress to malignancy. Dysplastic naevi are regarded as intermediate lesions of tumour progression between naevi and melanoma. They show S-phase ploidy and intermediate levels of genetic unstability. Cellular/hyperplastic nodules in congenital naevi may have mitoses but they are not abnormal. The nodules usually have pushing margins and merge with the adjacent banal component of the naevus. Naevi in pregnancy. Dermal and compound naevi of small congenital type in pregnancy may show increased numbers of normal-looking mitoses in the otherwise banal dermal nevomelanocytes and appear to be without clinical significance. Combined naevi are often mistaken clinically and histologically for melanoma because of their biclonal (occasionally triclonal) nature and variability or change in color or shape Frequent problems are combinations of common naevus (common acquired, congenital or dysplastic) associated with pigmented blue naevus (common blue, cellular blue or deep penetrating) or Spitz naevus (conventional, regressing or desmoplastic) 16. The blue naevus or Spitz naevus component may dominate the lesion and show an occasional mitosis. So-called ancient naevi may represent a combined naevus with a regressing or degenerating Spitzoid component. Blue naevi variants cause special problems. Dendritic blue naevi and sclerosing cellular blue naevi may have an infiltrative pattern similar to desmoplastic melanomas but the latter often have some junctional change, are almost invariably non-pigmented and are negative with HMB45. 17
5 Deep penetrating naevi frequently show moderate nuclear pleomorphism, abut nerves and have an occasional dermal mitosis. Rare cases, either large or with scattered mitoses, may involve a regional or sentinel lymph node. Whether this is a benign metastasis or an indication of future malignant progression is controversial. 17 Epithelioid blue naevi (as in Carney s syndrome) and other so-called pigmented epithelioid melanocytomas are also low grade melanocytic tumours that apparently frequently involve regional lymph nodes yet paradoxically appear to have a favourable prognosis 18 and should probably be regarded as being of uncertain malignant potential especially those in children and young adults and when associated with pseudoepitheliomatous hyperplasia. Balloon and clear cell naevi may be confused with their malignant counterparts. The naevi usually have bland nuclei and lack mitoses. Neurotised and desmoplastic common naevi can be confused with desmoplastic melanoma especially of pure type. The naevi, however, lack atypical junctional changes, dermal mitoses and scattered clusters of lymphocytes. Halo or regressing naevi may present with alarming color change, with a darkening centre and pale periphery, especially in children. Most of these atypical compound naevi have a dermal component of smaller darker nevomelanocytes disrupted by lymphocytes, a feature suggestive of early regression. An occasional dermal mitosis does not indicate malignancy. Though most frequent in children, they also occur in middle and old age groups. Acral naevi and genital naevi resemble dysplastic naevi elsewhere in the skin. Focal Pagetoid epidermal invasion, especially in the acral naevi is alone not an indication of malignancy. See also Tables 3 and 4. Table 3: Naevi of Acral Skin: Histopathological Features Which Can Cause Concern Suprabasilar melanocytes ( Pagetoid spread ) (30-79%) Atypical size, shape, location of junctional nests A subset (acral lentiginous naevi) show - Predominantly lentiginous growth - Poor circumscription - Asymmetry Small biopsies Table 4: Acral Naevi v Acral Melanoma: Features favouring melanoma Severe cytological atypia Lymphocytes abutting junctional zone Marked architectural disorder Increased density of melanocytes Excessive Pagetoid spread
6 Poor maturation Expansile growth Dermal mitoses and lymphocytes Spitz naevus and Spitzoid tumours are a common problem and share many of the histological features of melanoma (Table 5) Those with atypical features cause most concern and many are of uncertain biological behavior (Table 6). 20 Table 5: Features of Spitz Naevi Diameter usually < 6mm Telangiectatic vessels Symmetrical Nested & single cell Diffuse epidermal hyperplasia Pagetoid spread Hypergranulosis Maturation and often merging Terminal nests with dermal collagen Uniformity of cells Spindle/epithelioid cells and nests across lesion Mitotic figures <=2/mm² Kamino bodies Absent deep or abnormal mitoses Subepidermal clefts Table 6: Atypical Features for Spitz Naevus Diameter >10mm Peripheral Pagetoid Asymmetry epidermal invasion Ulceration Sparse Kamino bodies (children) Lack of maturation Marked cytological atypia Deep extension Irregular or multiple nucleoli Expansile dermal nests Dermal mitoses >2/mm² Epidermal thinning Deep mitoses Long thin rete ridges Abnormal mitoses An Approach to Atypical Cases. Complete excision is probably mandatory Avoid overdiagnosis to avoid excessive treatment and possible medico-legal action. Give a preferred diagnosis acknowledging the degree of uncertainty. Seek further opinions. The safest course may be to manage the lesion as a melanoma. 21 However, wide local excision may not be appropriate if there is likely to be unacceptable cosmetic disfigurement and any co-morbidity When there is uncertainty about whether a melanocytic tumour is benign or malignant the pathologist should document in their report the thickness of the tumour (and other important features of the tumour such as its mitotic rate and ulcerative state). This information may be utilised by the clinician to manage the patient as for a melanoma of equivalent thickness (and other prognostic parameters) if this is deemed appropriate. MELANOMAS PRONE TO CAUSE DIAGNOSTIC PROBLEMS (Table 7)
7 Table 7: Melanomas Prone to Cause Diagnostic Problems Naevoid melanoma Spitzoid melanoma Desmoplastic melanoma Regressed melanoma Naevoid melanomas mimic a benign naevus. Small and intermediate cell types are sometimes called minimal deviation melanoma (or Lawyer s melanoma because they may not be diagnosed until after they have metastasized and medicolegal action may follow). 14 Large and spindle cell types are called Spitzoid or Spitz naevus-like melanoma. A probable indolent variant resembling a dermal naevus develops on the lower limb of elderly females. Recognition of naevoid melanomas of smaller cell types requires a high index of suspicion and recognition of subtle architectural and cytological features. Architectural features are basic symmetry, good circumscription in a nodular or verrucous pattern lacking any significant radial growth phase or epidermal invasion. Long thin rete ridges, expansile or sheet-like growth and pseudomaturation are common. Subtle cytological atypia is present throughout though mitoses may be sparse and only superficial. HMB45 and Ki67 staining may be helpful in some cases. Desmoplastic melanoma. Desmoplastic melanomas may be difficult to detect clinically as they are usually nonpigmented and may resemble a scar, a dermatofibroma, a basal cell carcinoma or a poorly healing pyogenic granuloma. 9 Histologically they may be confused with immature scars (which may also have S-100 positive spindle cells and foci of lymphocytes), desmoplastic naevi (usually symmetrical lacking atypia, mitoses and lymphocytic foci); desmoplastic Spitz naevi (plump cells and associated epidermal thickening); sclerosing cellular blue naevus (usually HMB45 positive and have foci of melanin pigment); dermatofibroma (tapering storiform margins, epidermal thickening, absent lymphocytes) and with some soft tissue spindle cell sarcomas. Desmoplastic melanomas also often show an associated atypical junctional component (lentigo maligna / Hutchinson s melanotic freckle) and neurotropism. Most are HMB45 and Melan A (MART-1) negative. Pure forms (spindle cells only) probably have a better prognosis and less frequently involve regional lymph nodes than other melanomas. Regressed melanoma. If the lesion is on the back or posterior shoulder a history of a previous lesion may be unavailable. Key features are: 1. Epidermal thinning with loss of rete ridges. 2. Minimal or absent atypical junctional change.
8 3. A subepidermal band of angiofibroplasia (often up to 0.8mm thick) which may variably contain a few lymphocytes, melanophages and an occasional melanocyte. Capillaries are usually slightly increased. Melanoma Pathology Report The report should include all factors that affect accurate diagnosis, management and prognosis Currently the most important pathological prognostic factors for clinically localized primary melanoma are tumour thickness (Breslow), dermal mitotic rate (which also influences the rate of sentinel lymph node positivity) and ulceration. 1, Other factors are Clark level, site (trunk worse than extremities), age and gender (males worse than females). Margins of Excision. These are important in determining further management of atypical melanocytic lesions and melanomas. The main problem is accurately assessing the margins of lentigo maligna (Hutchinson s melanotic freckle) and some other melanocytic tumours where atypical melanocytes trail off at the edges. 32 To avoid excessive excisions, a marginal excision around the clinically affected area is usually done initially for definitive diagnosis. Wider excision (as per current melanoma treatment guidelines) can then be performed once a diagnosis of melanoma has been confirmed. # Adapted from McCarthy SW, Scolyer RA. Pitfalls and Important Issues in the Pathologic Diagnosis of Melanocytic Tumors. The Ochsner Journal 2010 (in press). REFERENCES 1. Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma.[see comment]. Lancet 2005;365(9460): Murali R, Thompson JF, Scolyer RA. Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment. Future Oncology 2008;4(4): Scolyer RA, McCarthy SW, Elder DE. Frontiers in melanocytic pathology. Pathology 2004;36(5): Scolyer RA, Thompson JF, McCarthy SW, Strutton GM, Elder DE. Incomplete biopsy of melanocytic lesions can impair the accuracy of pathological diagnosis.[erratum appears in Australas J Dermatol Nov;47(4):308]. Australasian Journal of Dermatology 2006;47(1):71-3; author reply Scolyer RA, Thompson JF, Stretch JR, Sharma R, McCarthy SW. Pathology of melanocytic lesions: new, controversial, and clinically important issues. Journal of Surgical Oncology 2004;86(4): Murali R, Sharma RN, Thompson JF, Stretch JR, Lee CS, McCarthy SW, et al. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Annals of Surgical Oncology 2008;15(1): Morey AL, Murali R, McCarthy SW, Mann GJ, Scolyer RA. Diagnosis of cutaneous melanocytic tumours by fourcolour fluorescence in situ hybridisation. Pathology 2009;41(4): Huang SK, Darfler MM, Nicholl MB, You J, Bemis KG, Tegeler TJ, et al. LC/MS-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis. PLoS One 2009;4(2):e McCarthy SW, Scolyer RA, Palmer AA. Desmoplastic melanoma: a diagnostic trap for the unwary. Pathology 2004;36(5): Scolyer RA, Thompson JF. Desmoplastic melanoma: a heterogeneous entity in which subclassification as "pure" or "mixed" may have important prognostic significance.[comment]. Annals of Surgical Oncology 2005;12(3): Crotty KA, Scolyer RA, Li L, Palmer AA, Wang L, McCarthy SW. Spitz naevus versus Spitzoid melanoma: when and how can they be distinguished?[see comment]. Pathology 2002;34(1): Shaw HM, Quinn MJ, Scolyer RA, Thompson JF. Survival in patients with desmoplastic melanoma.[comment]. Journal of Clinical Oncology 2006;24(8):e12; author reply e Thompson JF, Scolyer RA. Cooperation between surgical oncologists and pathologists: a key element of multidisciplinary care for patients with cancer. Pathology 2004;36(5):
9 14. McCarthy SW, Scolyer RA. Melanocytic lesions of the face: diagnostic pitfalls. Annals of the Academy of Medicine, Singapore 2004;33(4 Suppl): Murali R, McCarthy SW, Thompson JF, Scolyer RA. Melanocytic nevus with focal atypical epithelioid components (clonal nevus) is a combined nevus.[comment]. Journal of the American Academy of Dermatology 2007;56(5): Scolyer RA, Zhuang L, Palmer AA, Thompson JF, McCarthy SW. Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma. Pathology 2004;36(5): Murali R, McCarthy SW, Scolyer RA. Blue nevi and related lesions: a review highlighting atypical and newly described variants, distinguishing features and diagnostic pitfalls. Adv Anat Pathol 2009;16(6): Mandal RV, Murali R, Lundquist KF, Ragsdale BD, Heenan P, McCarthy SW, et al. Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up. Am J Surg Pathol 2009;33(12): Dahlstrom JE, Scolyer RA, Thompson JF, Jain S. Spitz naevus: diagnostic problems and their management implications. Pathology 2004;36(5): Busam KJ, Murali R, Pulitzer M, McCarthy SW, Thompson JF, Shaw HM, et al. Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas. Am J Surg Pathol 2009;33(9): Scolyer RA, Murali R, McCarthy SW, Thompson JF. Pathologic examination of sentinel lymph nodes from melanoma patients. Semin Diagn Pathol 2008;25(2): Chakera AH, Hesse B, Burak Z, Ballinger JR, Britten A, Caraco C, et al. EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging 2009;36(10): Karim RZ, van den Berg KS, Colman MH, McCarthy SW, Thompson JF, Scolyer RA. The advantage of using a synoptic pathology report format for cutaneous melanoma. Histopathology 2008;52(2): Azzola MF, Shaw HM, Thompson JF, Soong S-J, Scolyer RA, Watson GF, et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer 2003;97(6): Francken AB, Shaw HM, Thompson JF, Soong S-j, Accortt NA, Azzola MF, et al. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.[see comment]. Annals of Surgical Oncology 2004;11(4): Scolyer RA, Shaw HM, Thompson JF, Li L-XL, Colman MH, Lo SK, et al. Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. American Journal of Surgical Pathology 2003;27(12): Scolyer RA, Thompson JF, Shaw HM, McCarthy SW. The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma.[comment]. Journal of Cutaneous Pathology 2006;33(5):395-6; author reply Thompson JF, Scolyer RA, Kefford RF, Uren RF. Melanoma management in 2007.[comment]. Australian Family Physician 2007;36(7):487-8; author reply Thompson JF, Shaw HM, Hersey P, Scolyer RA. The history and future of melanoma staging. Journal of Surgical Oncology 2004;86(4): Murali R, Hughes MT, Fitzgerald P, Thompson JF, Scolyer RA. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma. Ann Surg 2009;249(4): Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma in the era of molecular profiling. Lancet 2009;374(9687): Stretch JR, Scolyer RA. Surgical strategies and histopathologic issues in the management of lentigo maligna. Ann Surg Oncol 2009;16(6): Van Es SL, Colman M, Thompson JF, McCarthy SW, Scolyer RA. Angiotropism is an independent predictor of local recurrence and in-transit metastasis in primary cutaneous melanoma. Am J Surg Pathol 2008;32(9): Ng JC, Swain S, Dowling JP, Wolfe R, Simpson P, Kelly JW. The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: experience of an Australian tertiary referral service. Archives of Dermatology 2010;146(3):234-9.
David B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma
Common Medicolegal Situations: Misdiagnosis of Melanoma David B. Troxel, MD Medical Director, The Doctors Company, Napa, California Clinical Professor Emeritus, University of California at Berkeley Past
More informationA PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL
A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL OBJECTIVES Discuss current trends and changing concepts in our understanding of
More informationDesmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC
R/O BCC Sabine Kohler, M.D. Professor of Pathology and Dermatology Dermatopathology Service Stanford University School of Medicine Clinical Information 74 y.o. man with lesion on left side of neck r/o
More informationDermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia
Dermatopathology Dr. Rafael Botella Estrada. Hospital La Fe de Valencia Melanoma and mimics Dr. Martin Mihm Malignant lesions result from the accumulation of mutations Class I lesions (benign) Class II
More informationFemale 18. Deeply pigmented lesion on trunk.?warty naevus?seborrhoeic keratosis?malignant melanoma. The best diagnosis is:
Female 18. Deeply pigmented lesion on trunk.?warty naevus?seborrhoeic keratosis?malignant melanoma. The best diagnosis is: A. deep penetrating naevus B. naevoid malignant melanoma C. pigment synthesising
More informationCase 26 Male 37. Right jawline 5mm nodule?keloid. The best diagnosis is:
Case 26 Male 37. Right jawline 5mm nodule?keloid. The best diagnosis is: A. Desmoplastic Spitz naevus B. Atypical Spitz Tumour C. Spitzoid melanoma D. Deep penetrating naevus E. Spitz naevus Case 26: M
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,500 108,000 1.7 M Open access books available International authors and editors Downloads Our
More informationAssociate Clinical Professor of Dermatology MUSC
Re-excision of Moderately Dysplastic Nevi: Should we or shouldn t we? John C. Maize, Jr, M.D. Dermatologist and Dermatopathologist Trident Dermatology, Charleston SC Associate Clinical Professor of Dermatology
More informationMelanoma Update: 8th Edition of AJCC Staging System
Melanoma Update: 8th Edition of AJCC Staging System Rosalie Elenitsas, M.D. Professor of Dermatology Director, Dermatopathology University of Pennsylvania DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY None
More informationPaediatric Dermatology Column: Case Report. Paediatric melanoma: challenges in diagnosis and management
Hong Kong J. Dermatol. Venereol. (2014) 22, 30-34 Paediatric Dermatology Column: Case Report Paediatric melanoma: challenges in diagnosis and management M Liu, CJA Henderson, M Gupta Paediatric melanoma,
More informationFORUM. Collaboration between clinicians and pathologists: a necessity for the optimal management of melanoma patients
Collaboration between clinicians and pathologists: a necessity for the optimal management of melanoma patients Richard Scolyer, 1,2 John Thompson, 1,3 Jonathan Stretch, 1,3 Stanley McCarthy 1,2 1 Sydney
More informationMelanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media
Melanoma and Dermoscopy Richard P. Usatine, MD, FAAFP Professor, Family and Community Medicine Professor, Dermatology and Cutaneous Surgery Medical Director, University Skin Clinic University of Texas
More informationHistopathology of Melanoma
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 48, 409-416 (1975) Histopathology of Melanoma G. J. WALKER SMITH Department ofpathology, Yale University School ofmedicine, 333 Cedar Street, New Haven, Connecticut
More informationBenign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more
Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more common on the trunk; but extremities, head and neck are
More informationBenign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc
1 Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc Benign lesions Seborrheic Keratoses: Warty, stuck-on Genetics and birthdays Can start in late
More informationالمركب النموذج--- سبيتز وحمة = Type Spitz's Nevus, Compound SPITZ NEVUS 1 / 7
SPITZ NEVUS 1 / 7 Epidemiology An annual incidence rate of 1.4 cases of Spitz nevus per 100,000 individuals has been estimated in Australia, compared with 25.4 per 100,000 individuals for cutaneous melanoma
More informationMelanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG
Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG At tumor board, a surgeon insists that all level II melanomas are invasive since they have broken through the
More information5/21/2018. Disclosures. Consulting: Myriad Genetics SciBase. Superficial Atypical Melanocytic Proliferations. SSM, LMM and (some of) their Simulants
Disclosures Consulting: Myriad Genetics SciBase Superficial Atypical Melanocytic Proliferations SSM, LMM and (some of) their Simulants 1 Melanomas and Nevi. Nevi are important mainly in relation to melanoma
More informationProtocol applies to melanoma of cutaneous surfaces only.
Melanoma of the Skin Protocol applies to melanoma of cutaneous surfaces only. Procedures Biopsy (No Accompanying Checklist) Excision Re-excision Protocol revision date: January 2005 Based on AJCC/UICC
More informationPathology of the skin. 2nd Department of Pathology, Semmelweis University
Pathology of the skin 2nd Department of Pathology, Semmelweis University Histology of the skin Epidermis: Stratum corneum Stratum granulosum Stratum spinosum Stratum basale Dermis: papillary and reticular
More informationHistopathology: skin pathology
Histopathology: skin pathology These presentations are to help you identify, and to test yourself on identifying, basic histopathological features. They do not contain the additional factual information
More informationPrimary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type
Primary Cutaneous Melanoma Pathology Reporting Proforma Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth DD MM YYYY Sex Male Female
More informationK Blessing, J J H Grant, D S A Sanders, M M Kennedy, A Husain, P Coburn
J Clin Pathol 2000;53:591 595 591 Papers Pathology, Aberdeen University, Foresterhill, Aberdeen AB25 2ZD, K Blessing Pathology, Birmingham University, Birmingham B15 2TT, D S A Sanders Pathology, Heartlands
More informationMalignant tumors of melanocytes: Part 1. Deba P Sarma, MD., Omaha
Malignant tumors of melanocytes: Part 1 Deba P Sarma, MD., Omaha The melanocytic tumor is one of the most difficult and confusing areas in Dematopathology. It is true that most (95%) of such lesions are
More informationMelanoma Underwriting Presented at 2018 AHOU Conference. Hank George FALU
Melanoma Underwriting Presented at 2018 AHOU Conference Hank George FALU MELANOMA EPIDEMIOLOGY 70-80,000 American cases annually Majority are in situ or thin > 20% are diagnosed age 45 8-9,000 melanoma
More informationDr. Brent Doolan, BSc MBBS MPH
Impact of partial biopsies on the need for complete excisional surgery in the management of cutaneous melanomas: A multi-centre review Dr. Brent Doolan, BSc MBBS MPH Peter MacCallum Cancer Centre, Melbourne
More informationCutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA)
The Sentinel Node in Head and Neck Melanoma Cutaneous Melanoma: Epidemiology (USA) 6 th leading cause of cancer among men and women 68,720 new cases of invasive melanoma in 2009 8,650 deaths from melanoma
More informationMelanocytic Lesions: Use of Immunohistochemistry and Special Studies Napa Valley 2018
Melanocytic Lesions: Use of Immunohistochemistry and Special Studies Napa Valley 2018 Victor G. Prieto, MD, PhD Professor Depts. of Pathology and Dermatology University of Texas - MD Anderson Cancer Center
More informationMultiple Primary Melanoma in a Thai Male: A Case Report
Case Report Multiple Primary Melanoma in a Thai Male: A Case Report J Med Assoc Thai 2014; 97 (Suppl. 2): S234-S238 Full text. e-journal: http://www.jmatonline.com Kittisak Payapvipapong MD*, Pinyapat
More informationDermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.
Squamous cell carcinoma (SCC): A common malignant tumor of keratinocytes arising in the epidermis, usually from a precancerous condition: 1- UV induced actinic keratosis, usually of low grade malignancy.
More informationEARLY ONLINE RELEASE
EARLY ONLINE RELEASE Note: This article was posted on the Archives Web site as an Early Online Release. Early Online Release articles have been peer reviewed, copyedited, and reviewed by the authors. Additional
More informationDiagnoses of Cases 1. Lentigo, other melanosis and the acquired nevus 2. Variations on the acquired nevus 3. Dermal melanocytosis
Diagnoses of Cases 1. Lentigo, other melanosis and the acquired nevus 1 1A. Lentigo simplex 4 1B. Psoralens and ultraviolet A (PUVA) lentigo 6 1C. Solar lentigo 8 1D. Café au lait macule 10 1E. Ink-spot
More informationConflict of Interest 9/2/2014. Pathogenesis and Comparison of Atypical Spitz Nevi vs Benign Spitz, and Childhood Melanoma
Pathogenesis and Comparison of Atypical Spitz Nevi vs Benign Spitz, and Childhood Melanoma Martin C. Mihm Jr., M.D., F.A.C.P. Harvard Medical School Brigham and Women s Hospital Dana Farber Cancer Center
More informationWays to get into trouble, ideas on avoiding trouble, and diagnostic approaches to keep trouble at bay
Pitfalls in the diagnosis of melanocytic tumors Timothy McCalmont, MD University of California, San Francisco Ways to get into trouble, ideas on avoiding trouble, and diagnostic approaches to keep trouble
More informationManagement of pediatric melanocytic lesions
Open Journal of Clinical & Medical Case Reports Management of pediatric melanocytic lesions Volume 3 (2017) Issue 8 ISSN 2379-1039 Jin Kim, BS; Emmanuel Gabriel MD, PhD; Weiguo Liu MD, PhD; Lin Lin MD,
More informationUpdate on 8 th Edition Cutaneous AJCC Staging of Primary Cutaneous Melanoma. Michael T. Tetzlaff MD, PhD
Update on 8 th Edition Cutaneous AJCC Staging of Primary Cutaneous Melanoma Michael T. Tetzlaff MD, PhD Associate Professor Departments of Pathology (Dermatopathology) and Translational and Molecular Pathology
More informationأملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5
Leiomyosarcoma 1 / 5 EPIDEMIOLOGY Exact incidence is unknown, but older studies suggest that leiomyosarcomas comprise approximately 3 percent of soft-tissue sarcomas. Superficial leiomyosarcoma occurs
More informationBasal cell carcinoma 5/28/2011
Goal of this Presentation A practical approach to the diagnosis of cutaneous carcinomas and their mimics Thaddeus Mully, MD University of California San Francisco To review common non-melanoma skin cancers
More informationMalignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha
Malignant tumors of melanocytes : Part 3 Deba P Sarma, MD., Omaha Let s go over one case of melanoma using the following worksheet. Of the various essential information that needs to be included in the
More informationGuy Perrot (Ги Перро)
НАУЧНО-ПРАКТИЧЕСКАЯ КОНФЕРЕНЦИЯ (МАСТЕР-КЛАСС) «ПРАКТИЧЕСКИЕ АСПЕКТЫ ДИАГНОСТИКИ И ЛЕЧЕНИЯ МЕЛАНОМЫ КОЖИ» DIAGNOSTIC AND PITFALLS IN MELANOMA Guy Perrot (Ги Перро) MD PHD pathologist, University Hospital
More informationEpithelial Cancer- NMSC & Melanoma
Epithelial Cancer- NMSC & Melanoma David Chin MB, BCh, BAO, LRCP, LRCS (Ireland) MCh(MD), PhD (UQ), FRCS, FRACS (Plast) Plastic & Reconstructive Surgeon Visiting Scientist Melanoma Genomic Group & Drug
More informationF006 Imaging in Dermatology Melanocytic Neoplasia Clinical-Confocal-Pathological-Correlations
F006 Imaging in Dermatology Melanocytic Neoplasia Clinical-Confocal-Pathological-Correlations Melissa Gill, MD SkinMedical Research and Diagnostics Dobbs Ferry, NY, USA Department of Pathology SUNY Downstate
More informationCitation for published version (APA): Niebling, M. G-J. (2014). Improving Staging Accuracy in Melanoma Groningen: s.n.
University of Groningen Improving Staging Accuracy in Melanoma Niebling, Maarten Gert-Jan IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it.
More information1/10/2018. Soft Tissue Tumors Showing Melanocytic Differentiation. Overview. Desmoplastic/ Spindle Cell Melanoma
2016 MFMER slide-1 2016 MFMER slide-2 2016 MFMER slide-3 Soft Tissue Tumors Showing Melanocytic Differentiation Andrew L. Folpe, M.D. Professor of Laboratory Medicine and Pathology Mayo Clinic, Rochester,
More informationSpringer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone
Concise Reference Staging and Diagnosing Cutaneous Melanoma Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone Extracted from Handbook of Cutaneous Melanoma: A Guide to Diagnosis and Treatment Published
More informationPolypoid Melanoma, A Virulent Variant of the Nodular Growth Pattern
Polypoid Melanoma, A Virulent Variant of the Nodular Growth Pattern ELIZABETH A. MANCI, M.D., CHARLES M. BALCH, M.D..TARIQ M. MURAD, M.D., PH.D., AND SENG/JAW SOONG, PH.D. Manci, Elizabeth A., Balch, Charles
More informationCase RAC7783. M46. Ear. Mole. r/o MM.?Blue naevus RAC7783
Case RAC7783. M46. Ear. Mole. r/o MM.?Blue naevus RAC7783 Pie Chart Participants N=74 Benign: 48 N=74 Blue naevus: 38 Intradermal: 12 DPN: 10 Compound 3 Clonal: 3; Spitz 2; Special Site: 1; Congenital:
More informationClinical characteristics
Skin Cancer Fernando Vega, MD Seattle Healing Arts Clinical characteristics Precancerous lesions Common skin cancers ACTINIC KERATOSIS Precancerous skin lesions Actinic keratoses Dysplastic melanocytic
More informationSimulators of melanoma
Simulators of melanoma Philip E. LeBoit, M.D. Depts. of Pathology and Dermatology University of California, San Francisco Simulators of melanoma Simulators of melanoma in situ Melanocytic Non-melanocytic
More information6/22/2015. Original Paradigm. Correlating Histology and Molecular Findings in Melanocytic Neoplasms
6 Correlating Histology and Molecular Findings in Melanocytic Neoplasms Pedram Gerami MD, Associate Professor of Dermatology and Pediatrics at Northwestern University Disclosures: I have been a consultant
More informationLess Common Variants of Cutaneous Melanoma
Less Common Variants of Cutaneous Melanoma Raymond L. Barnhill* 1, G. Peter Sarantopoulos 1, and Kapil Gupta 2 1 Department of Pathology and Laboratory Medicine, University of California, Los Angeles,
More informationIT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY
IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY Skin, Bones, and other Private Parts Symposium Dermatology Lectures by Debra Shelby, PhD, DNP, FNP-BC, FADNP, FAANP Debra Shelby,
More informationS everal morphological features are frequently used in the
1194 ORIGINAL ARTICLE Interobserver reproducibility of histological features in cutaneous malignant melanoma C Urso, F Rongioletti, D Innocenzi, C Saieva, D Batolo, S Chimenti, R Filotico, R Gianotti,
More informationDermatologica Sinica
DERMATOLOGICA SINICA 30 (2012) 57e61 Contents lists available at SciVerse ScienceDirect Dermatologica Sinica journal homepage: http://www.derm-sinica.com CASE REPORT Pigmented epithelioid melanocytoma:
More informationSTUDY. The Impact of Partial Biopsy on Histopathologic Diagnosis of Cutaneous Melanoma
STUDY The Impact of Partial Biopsy on Histopathologic Diagnosis of Cutaneous Melanoma Experience of an Australian Tertiary Referral Service Jonathan C. Ng, MBBS, MBiomedSc; Sarah Swain, MBBS, FRCPA; John
More informationAn Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center
An Overview of Melanoma Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center Melanoma Statistics Median age at presentation 45-55 55 years Incidence: 2003 54,200 cases
More informationInteresting Case Series. Desmoplastic Melanoma
Interesting Case Series Desmoplastic Melanoma Anthony Maurice Kordahi, MD, Joshua B. Elston, MD, Ellen M. Robertson, MD, and C. Wayne Cruse, MD Division of Plastic Surgery, Department of Surgery, University
More informationMelanoma. Kaushik Mukherjee MD A. Scott Pearson MD
Melanoma Kaushik Mukherjee MD A. Scott Pearson MD Disclosures You still have to study Not all inclusive No Western blots Extensive use of Google Image Search and Sabiston Melanoma Basics 8 th most common
More informationDesmoplastic Melanoma: Clinical Behavior and Management Implications
Desmoplastic Melanoma: Clinical Behavior and Management Implications Collier S. Pace, MD, a Jyoti P. Kapil, MD, b Luke G. Wolfe, MS, c Brian J. Kaplan, MD, c and James P. Neifeld, MD c a Division of Plastic
More informationMichael T. Tetzlaff MD, PhD
Molecular alterations informing the diagnosis of melanocytic tumors Michael T. Tetzlaff MD, PhD Associate Professor Department of Pathology, Section of Dermatopathology Department of Translational and
More informationContrast with Australian Guidelines A/Pr Pascale Guitera,
Contrast with Australian Guidelines A/Pr Pascale Guitera, Dermatologist, Sydney University NO CONFLICT OF INTEREST Sydney Melanoma Diagnostic Centre, RPAH 2011 2008 225 pages 16 pages http://www.cancer.org.au/file/healthprofessionals/clinica
More informationThere is NO single Melanoma Stain. > 6000 Mutations in Melanoma. What else can be done to discriminate atypical nevi from melanoma?
Las Vegas Fall Clinical 2016: The Assessment and Diagnosis of Melanoma Whitney A. High, MD, JD, MEng Associate Professor, Dermatology & Pathology Director of Dermatopathology (Dermatology) University of
More informationUpdate on Spitzoid and Blue nevus-like melanocytic lesions Emphasis on molecular studies informing diagnosis, prognosis and therapy
Update on Spitzoid and Blue nevus-like melanocytic lesions Emphasis on molecular studies informing diagnosis, prognosis and therapy Michael T. Tetzlaff MD, PhD Associate Professor Department of Pathology,
More informationToby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma
Distinguishing Pigmented Skin Lesions and Melanoma Toby Maurer, MD University of California, San Francisco Epidemiology of Melanoma Lifetime risk of an American developing melanoma 1935: 1 in 1500 1980:
More informationThe Relevance of Cytologic Atypia in Cutaneous Neural Tumors
The Relevance of Cytologic Atypia in Cutaneous Neural Tumors Recent Findings - New Developments New Problems Zsolt B. Argenyi, M.D. Professor of Pathology & Dermatology Director of Dermatopathology Department
More informationThe Enigmatic Spitz Lesion
The Enigmatic Spitz Lesion The Dawn of Spitz S Spitz Sophie Spitz Melanomas of Childhood ; Am J Pathol 1948 1910-1956 13 children (18 mo - 12 yrs) 12/13 had a benign clinical course Sophie Spitz Born 1910
More informationPublished Ahead of Print on December 14, 2009 as /JCO J Clin Oncol by American Society of Clinical Oncology
Published Ahead of Print on December 14, 2009 as 10.1200/JCO.2009.24.7734 The latest version is at http://jco.ascopubs.org/cgi/doi/10.1200/jco.2009.24.7734 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L
More informationCase Report Micromelanomas: A Review of Melanomas 2mmand a Case Report
Case Reports in Oncological Medicine, Article ID 206260, 4 pages http://dx.doi.org/10.1155/2014/206260 Case Report Micromelanomas: A Review of Melanomas 2mmand a Case Report Sharad P. Paul 1,2,3 1 Skin
More informationPatient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival
MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS
More informationSelected Pseudomalignant Soft Tissue Tumors of the Skin and Subcutis
Selected Pseudomalignant Soft Tissue Tumors of the Skin and Subcutis Andrew L. Folpe, M.D. Professor of Laboratory Medicine and Pathology Mayo Clinic, Rochester, MN folpe.andrew@mayo.edu 2016 MFMER slide-1
More informationMelanoma and the genes: Molecular alterations informing the diagnosis of melanocytic tumors
Melanoma and the genes: Molecular alterations informing the diagnosis of melanocytic tumors Michael T. Tetzlaff MD, PhD Associate Professor Department of Pathology, Section of Dermatopathology Department
More informationUpdates on Melanoma: Are You Following the Latest Guidelines of Care? Jerry Brewer, MD
Updates on Melanoma: Are You Following the Latest Guidelines of Care? Jerry Brewer, MD Disclosure Statement Update on Melanoma Are You Following the Latest Guidelines of Care? I, Jerry D. Brewer, MD, do
More informationToby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma
Distinguishing Pigmented Skin Lesions and Melanoma Toby Maurer, MD University of California, San Francisco Epidemiology of Melanoma Lifetime risk of an American developing melanoma 1935: 1 in 1500 1980:
More informationMaligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT
Maligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT Two different neoplasia in the same biopsy material called
More informationGenetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology
Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology Outline Germline testing CDKN2A BRCA2 BAP1 Somatic testing Gene expression profiling (GEP) BRAF Germline vs Somatic testing
More informationIdentifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018
Identifying Skin Cancer Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018 American Cancer Society web site Skin Cancer Melanoma Non-Melanoma
More informationDysplasia, Mimics and Other Controversies
Dysplasia, Mimics and Other Controversies Mary S. Richardson, MD Dept. of Pathology Medical University of South Carolina Charleston, SC Notice of Faculty Disclosure In accordance with ACGME guidelines,
More informationWHAT DOES THE PATHOLOGY REPORT MEAN?
Melanoma WHAT IS MELANOMA? Melanoma is a type of cancer that affects cells called melanocytes. These cells are found mainly in skin but also in the lining of other areas such as nose and rectum, and also
More informationPATHOLOGY OF THE SKIN 2. Tumours of the skin
PATHOLOGY OF THE SKIN 2. Tumours of the skin Máirín E. McMenamin MB MRCPI FRCPath Dip (Dermatopathol) RCPath St. James s Hospital and University of Dublin, Trinity College Tumour (Neoplasia) Benign or
More informationDesmoplastic Melanoma: Surgical Management and Adjuvant Therapy
Desmoplastic Melanoma: Surgical Management and Adjuvant Therapy Dale Han, MD Assistant Professor Department of Surgery Section of Surgical Oncology No disclosures Background Desmoplastic melanoma (DM)
More informationUpdate on Cutaneous Mesenchymal Tumors. Thomas Brenn
Update on Cutaneous Mesenchymal Tumors Thomas Brenn Cutaneous Mesenchymal Tumours Wide morphological and biological spectrum Myofibroblastic, smooth muscle, neural, vascular, apidocytic, undifferentiated;
More informationVernon K. Sondak. Department of Cutaneous Oncology Moffitt Cancer Center Tampa, Florida
Vernon K. Sondak Department of Cutaneous Oncology Moffitt Cancer Center Tampa, Florida Australasian Melanoma Conference 2016 Sydney, NSW, Australia October 29, 2016 Disclosures Dr. Sondak is a compensated
More informationBlue Melanocytic Proliferations
Blue Melanocytic Proliferations Labib R. Zakka M.D., M.A. Research Fellow Melanoma Program Department of Dermatology Brigham and Women s Hospital Harvard Medical School Conflicts of Interest No conflicts
More informationORAL MELANOMA Definition Epidemiology Clinical Presentation
ORAL MELANOMA Definition Melanoma is a highly malignant neoplasia, arising from melanocytes, the cells that produce the brownish pigment melanin. Melanin is the determinant in skin colour and protects
More informationAtypical Nevi When to Re-excise. Catherine Barry, DO Dermatopathologist
Atypical Nevi When to Re-excise Catherine Barry, DO Dermatopathologist Why talk about skin cancer? Because it s the most common type of cancer! Non-melanoma Skin Cancers Basal Cell Carcinoma Squamous Cell
More informationNeoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath
Neoplasia 2018 Lecture 2 Dr Heyam Awad MD, FRCPath ILOS 1. List the differences between benign and malignant tumors. 2. Recognize the histological features of malignancy. 3. Define dysplasia and understand
More informationLichenoid Tissue Reaction in Malignant Melanoma A Potential Diagnostic Pitfall
natomic Pathology / LICHENOID TISSUE RECTION IN MLIGNNT MELNOM Lichenoid Tissue Reaction in Malignant Melanoma Potential Diagnostic Pitfall CPT Scott R. Dalton, MC, US, 1,3 Capt Matt. aptista, USF, MC,
More informationNAACCR Webinar Series 1
Collecting Cancer Data: Melanoma 2013 2014 NAACCR Webinar Series April 3, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching
More informationMichael T. Tetzlaff MD, PhD
Update on American Joint Cancer Committee (AJCC) staging system for primary cutaneous melanoma Emphasis on concise and accurate reporting of primary and metastatic melanoma for effective risk stratification
More informationMECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 12, :30 am 11:00 am
MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB Friday, February 12, 2012 9:30 am 11:00 am FACULTY COPY GOALS: Describe the basic clinical and morphologic features of various
More informationMelanoma 6/2/2011. Classification and Prognosis. Melanoma Statistics. American Cancer Society
University of Pennsylvania, Ben Franklin in front of Charles Addams Building Melanoma Classification and Prognosis Emphasizing Pathology & History David Elder University of Pennsylvania Melanoma Statistics
More informationCommon Benign Lesions and Skin Cancers. 22nd May 2015 Dr Mark Foley
Common Benign Lesions and Skin Cancers 22nd May 2015 Dr Mark Foley Thank you for downloading this file. This intended to supplement the presentation given at the NZ Wound Care Conference, it is not intended
More informationCase Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors
CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior
More informationMalignant Melanoma Early Stage. A guide for patients
This melanoma patient brochure is designed to help educate melanoma patients and their caregivers. It was developed under the guidance of Dr. Michael Smylie, Professor, Department of Oncology, University
More informationObjectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells
2013 California Society of Pathologists 66 th Annual Meeting San Francisco, CA Atypical Glandular Cells to Early Invasive Adenocarcinoma: Cervical Cytology and Histology Christina S. Kong, MD Associate
More informationBrief Report. Shivanand Gundalli 1, Smita Kadadavar 1, Somil Singhania 1, Rutuja Kolekar 2 INTRODUCTION. Melanocytic Nevus
Our Dermatology Online Histopathological spectrum of benign melanocytic nevi our experience in a tertiary care centre Shivanand Gundalli 1, Smita Kadadavar 1, Somil Singhania 1, Rutuja Kolekar 2 1 Department
More informationIndex. Springer-Verlag Berlin Heidelberg 2017 J.A. Plaza, V.G. Prieto, Pathology of Pigmented Skin Lesions, DOI /
A Acral lentiginous (mucosal lentiginous) melanoma, 483 Acral lentiginous melanoma (ALM) asymmetric and irregular lentiginous junctional growth, 431 clinical features, 427 428 differential diagnosis, 428
More informationThis is a repository copy of Easily missed? Amelanotic melanoma. White Rose Research Online URL for this paper:
This is a repository copy of Easily missed? Amelanotic melanoma. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/127789/ Version: Accepted Version Article: Muinonen-Martin,
More informationRegression 2/3/18. Histologically regression is characterized: melanosis fibrosis combination of both. Distribution: partial or focal!
Regression Margaret Oliviero MSN, ARNP Harold S. Rabinovitz MD Histologically regression is characterized: melanosis fibrosis combination of both Distribution: partial or focal! Dermatoscopic terminology
More information